TSS
SPRY icon

Two Sigma Securities’s ARS Pharmaceuticals SPRY Stock Holding History

Two Sigma Securities’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$94.8K Buy
+11,811
New +$113K 0.01% 1179
2022
Q4 		– Sell
-12,740
Closed -$67K – 3221
2022
Q3 		$67K Buy
+12,740
New +$62.8K ﹤0.01% 2147

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Two Sigma Securities's SPRY Position: Q1 2026 in Review

Two Sigma Securities opened a new position in ARS Pharmaceuticals (SPRY) in Q1 2026: 11,811 shares worth $94.8K. The stake represents 0.01% of the portfolio and ranks #1179 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in SPRY as recently as Q3 2022.

Two Sigma Securities first reported a position in SPRY in Q3 2022 and has held it in 2 quarters since. 202 funds tracked by Wall St. Rank hold SPRY as of Q1 2026.

  • Two Sigma Securities held 11,811 shares of ARS Pharmaceuticals worth $94.8K as of Q1 2026.
  • ARS Pharmaceuticals was a new Two Sigma Securities position in Q1 2026.
  • ARS Pharmaceuticals made up 0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1179 holding.
  • Two Sigma Securities first reported a position in ARS Pharmaceuticals in Q3 2022 and has held it in 2 quarters since.
  • 202 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.